Somatostatin Analogues in Bronchial Neuroendocrine Tumors: Symptom Control and Anti-Proliferative Role

#1146

Introduction: There is no established fist-line medical treatment for advanced bronchial NETs.

Aim(s): To assess the symptom-control & antiproliferative efficacy (time-to-first-radiological-progression) of somatostatin-analogues (SA).

Materials and methods: Patients with histologically confirmed bronchial-NETs (typical/atypical-carcinoids), with & without primary resection, and with tumour-uptake in Octreoscan &/or Ga-68-Octreotate PET were retrospectively reviewed. None had received any systemic treatment prior to SA-commencement. A symptom-score & radiological assessment by RECIST were utilized.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Efthimia K

Authors: Karra E, Polycarpou A, Tanaskovic N, Garcia-Hernandez J, Mullan M,

Keywords: Bronchial NET,